Chanson, N., Galvagni, A., Ramos-Casals, M., Ruiz, J. I., Suijkerbuijk, K. P. M., Gente, K., . . . Lambotte, O. (2025). Immune checkpoint inhibitors-associated vasculitis: A heterogeneous condition with possible severe disease course. Rheumatology, 64(6), . https://doi.org/10.1093/rheumatology/keae711
Chicago-Zitierstil (17. Ausg.)Chanson, Noémie, et al. "Immune Checkpoint Inhibitors-associated Vasculitis: A Heterogeneous Condition with Possible Severe Disease Course." Rheumatology 64, no. 6 (2025). https://doi.org/10.1093/rheumatology/keae711.
MLA-Zitierstil (9. Ausg.)Chanson, Noémie, et al. "Immune Checkpoint Inhibitors-associated Vasculitis: A Heterogeneous Condition with Possible Severe Disease Course." Rheumatology, vol. 64, no. 6, 2025, https://doi.org/10.1093/rheumatology/keae711.